|
|
Article: Amedisys Reaffirms Guidance.
- Article from:
- Managed Care Weekly Digest
- Article date:
- September 21, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Amedisys, Inc. (NASDAQ: AMED) (the "Company"), one of America's leading home health and hospice nursing companies, announced that it has reaffirmed its guidance for 2009. For the year, net service revenue is expected to be in the range of $1.475 billion to $1.5 billion, and diluted earnings per share is expected to be in the range of $4.75 to $4.90 based on an estimated 27.8 million shares outstanding, excluding the effects of future acquisitions that may occur (see also Amedisys, Inc.).
Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock trades on the NASDAQ Global Select Market under the symbol "AMED". This press release includes ...